Related Experiment Videos
[Life-threatening acute lower gastrointestinal bleeding in patients with Crohn's disease]
M Barreiro de Acosta1, S Seijo Ríos, J E Domínguez Muñoz
1Servicio de Aparato Digestivo, Hospital Clínico Universitario, C/ Choupana, s/n. 15706 Santiago de Compostela, A Coruña, Spain. manubarreiro@hotmail.com
Insights
Acute severe gastrointestinal (GI) bleeding is a rare complication in Crohn's disease (CD) patients, occurring in 1.7% of cases. This severe bleeding primarily affects young patients with inflammatory ileal CD and often necessitates urgent surgical intervention.
Area of Science:
- Gastroenterology
- Internal Medicine
- Clinical Research
Context:
- Crohn's disease (CD) is a chronic inflammatory bowel disease.
- Gastrointestinal (GI) bleeding is a potential complication of CD.
- Understanding the frequency and risk factors for severe GI bleeding in CD is crucial for patient management.
Purpose:
- To evaluate the frequency of acute severe GI bleeding in CD patients.
- To identify potential risk factors associated with severe GI bleeding in CD, including clinical features, environmental factors, and genetic alterations.
Summary:
- A study of 174 CD patients found that 1.7% experienced severe acute lower GI bleeding.
- All affected patients required surgery, representing 3.4% of CD-related surgeries.
- The bleeding occurred in young patients (<25 years) with inflammatory ileal CD (L1-B1 Vienna Classification).
- No association was found between acute bleeding and evaluated risk factors like smoking or specific gene mutations.
Impact:
- Acute severe GI bleeding is a rare but serious complication in CD.
- Diagnosis often requires endoscopy and arteriography.
- Urgent surgical intervention is typically necessary for hemorrhage control.
Objective:
We aimed at evaluating the frequency of acute severe bleeding in CD and its potential association to some risk factors, including clinical features of CD, environmental factors, and genetic alterations.
Material And Methods:
174 consecutive patients with CD (103 female (59%) and 71 men (41%), with a mean age of 37 years) were included. We analyzed all major acute lower gastrointestinal (GI) hemorrhage related to CD. Potential risk factors like smoking, site of disease, and presence of gene mutations in CARD15, TLR-4, and CD14 were also analyzed.
Results:
Three patients (1.7%) suffered from severe acute lower GI bleeding. All patients required surgery to resolve their hemorrhage, and this indication represented 3.4% of all surgical procedures related to CD. All three patients were young ( < 25 years) and suffered ileal CD with inflammatory pattern (L1-B1 in the Vienna Classification). No relationship was found between acute bleeding and any of the potential risk factors evaluated.
Conclusions:
Acute severe GI bleeding is a rare, but severe complication in CD patients, and presents mainly in patients with inflammatory ileal disease. An association of endoscopy and arteriography is necessary for diagnosis. Urgent surgery is usually required in these patients.
Related Concept Videos
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease